Media coverage
1
Media coverage
Title Lebrikizumab Therapy Improved QoL, Mental Health Outcomes in Patients with Atopic Dermatitis; In a study of persons with moderate-to-severe atopic dermatitis, lebrikizumab monotherapy for 16 weeks resulted in improved quality of life and mental health. Media name/outlet Patient Care Country/Territory United States Date 10/09/24 Persons Peter Lio